XLON
SYNC
Market cap984mUSD
Oct 09, Last price
123.20GBP
1D
0.33%
1Q
13.54%
Jan 2017
-9.17%
IPO
18.83%
Name
Syncona Ltd
Chart & performance
P/E
—
P/S
13.07
EPS
—
Div yield, %
—
Shrs. gr., 5y
-1.93%
Rev. gr., 5y
-6.10%
Revenues
57m
P
Net income
-9m
L-93.85%
CFO
23m
-46.87%
Dividend
Jun 20, 20192.3 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Syncona Ltd. is a closed-end investment fund, which engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. Its portfolio includes commercial companies, late-stage clinical companies, clinical companies, and pre-clinical companies. The company was founded on August 14, 2012 and is headquartered in St. Peter Port, the United Kingdom.
Key people
Non-Executive Independent Chairman of the Board · since 2020
Magdalena Jonikas
Partner of Syncona Investment Management Ltd · since 2024
Elisa Petris
Partner of Syncona Investment Management Ltd · since 2024
Christopher Hollowood
Chief Executive Officer of Syncona Investment Management Limited · since 2024
Roel Bulthuis
Managing Partner, Head of Investments of Syncona Investment Management Limited · since 2022
Kate Butler
Chief Financial Officer of Syncona Investment Management Limited · since 2024
Edward Hodgkin
Managing Partner of Syncona Investment Management Ltd · since 2022
Executive Partner of Syncona Investment Management Ltd · since 2024
Melanie Gee
Non-Executive Independent Chairman of the Board · since 2020
Julie Cherrington
Non-Executive Independent Director · since 2022
Senior Non-Executive Independent Director · since 2025
Gian Reverberi
Non-Executive Independent Director · since 2018
John Roche
Non-Executive Independent Director · since 2024
Headquarters & legal address
FRANCES HOUSE, P O BOX 273
SIR WILLIAM PLACE
ST PETER PORT GY1 3RD
GG
SIR WILLIAM PLACE
ST PETER PORT GY1 3RD
GG
Previous name
BACIT LIMITED
Previous name
BATTLE AGAINST CANCER INVESTMENT TRUST LIMITED
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||